Publicaciones en colaboración con investigadores/as de Universidad de Zaragoza (10)

2024

  1. APOE and familial hypercholesterolemia

    Current Opinion in Lipidology, Vol. 35, Núm. 4, pp. 195-199

2023

  1. Contribution of APOE Genetic Variants to Dyslipidemia

    Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 43, Núm. 6, pp. 1066-1077

2022

  1. Lipoprotein(a) in hereditary hypercholesterolemia: Influence of the genetic cause, defective gene and type of mutation

    Atherosclerosis, Vol. 349, pp. 211-218

2021

  1. Diagnostic yield of sequencing familial hypercholesterolemia genes in individuals with primary hypercholesterolemia

    Revista Espanola de Cardiologia, Vol. 74, Núm. 8, pp. 664-673

  2. Lipoprotein metabolism in familial hypercholesterolemia

    Journal of Lipid Research, Vol. 62

2020

  1. Predicted pathogenic mutations in STAP1 are not associated with clinically defined familial hypercholesterolemia

    Atherosclerosis, Vol. 292, pp. 143-151

2018

  1. Site-specific O-glycosylation of members of the low-density lipoprotein receptor superfamily enhances ligand interactions

    Journal of Biological Chemistry, Vol. 293, Núm. 19, pp. 7408-7422

2016

  1. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Autophagy

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Autophagy, Vol. 12, Núm. 1, pp. 1-222

  3. The p.Leu167del mutation in APOE gene causes autosomal dominant hypercholesterolemia by down-regulation of LDL receptor expression in hepatocytes

    Journal of Clinical Endocrinology and Metabolism, Vol. 101, Núm. 5, pp. 2113-2121